Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
Adetola  Kassim

Adetola Kassim, M.D., M.S.

Associate Professor of Medicine (Hematology/Oncology)
Director, Adult Sickle Cell Disease Program
Clinical Director, Adult Stem Cell Transplant Program
Hematologist/Oncologist

  • Appointments
    615-936-8422
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Vanderbilt University Medical Center
    (615) 322-5000

    Office
    615-936-3851
  • Faxes

    Clinic Fax
    615-936-1812
  • Addresses
    Clinic
    1301 Medical Center Drive
    3903 The Vanderbilt Clinic
    Nashville, TN 37232-5505

    Vanderbilt University Medical Center
    1211 Medical Center Drive
    Nashville, TN 37232
    Website

    Office
    Division of Hematology/Oncology
    3927 The Vanderbilt Clinic
    1301 Medical Center Dr.
    Nashville, TN 37232-5505
Profile

Dr. Kassim specializes in hematology and hematopoietic stem cell transplantation. His clinical research efforts is focused on harnessing the use of stem cell transplant technology in improving patient care outcomes, both for hematologic malignancies (such as leukemias, lymphomas and myelomas) as well as benign hematologic disorders such a sickle cell disease, aplastic anemias and bone marrow failure states.
Read more...

Dr. Kassim specializes in hematology and hematopoietic stem cell transplantation. His clinical research efforts is focused on harnessing the use of stem cell transplant technology in improving patient care outcomes, both for hematologic malignancies (such as leukemias, lymphomas and myelomas) as well as benign hematologic disorders such a sickle cell disease, aplastic anemias and bone marrow failure states.

He directs the adult sickle cell disease program, and in conjunction with the Department of Pediatrics at Vanderbilt Childrens Hospital and Meharry Medical Center, have helped develop a Sickle Cell Disease Center of Excellence to address the need of patients and families affected by the disorder. Research in the area of sickle cell disease focuses mainly on the study of epigenetic determinants of disease expression, development of a patient centered medical home model of care and use of evidence based management paradigms to improve both patient satisfaction and care outcomes. He is investigating the use of alternate donor and reduced intensity hematopoietic stem cell transplant approaches as a curative modality for the disease.

Education
  • Internal Medicine- Mount Sinai Hospital Program, New York, NY.
  • Hematology/Oncology- Albert Einstein College of Medicine, Montefiore Medical cencer, Bronx, New York
  • Bone marrow Transplant- Johns Hopkins Hospital, Baltimore, Maryland
Research Description

Incidence of pulmonary hypertension in adult sickle cell patients. A prospective case-controlled study.

Publications
  • Sanger M, Jordan L, Pruthi S, Day M, Covert B, Merriweather B, Rodeghier M, DeBaun M, Kassim A. Cognitive deficits are associated with unemployment in adults with sickle cell anemia. J Clin Exp Neuropsychol. 2016 Aug; 38(6): 661-71. PMID: 27167865, DOI: 10.1080/13803395.2016.1149153, ISSN: 1744-411X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27167865.
  • Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation [letter]. Haematologica [print-electronic]. 2016 May; 101(5): e204-8. PMID: 26819055, PII: haematol.2015.139501, DOI: 10.3324/haematol.2015.139501, ISSN: 1592-8721.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26819055.
  • Kassim AA, Pruthi S, Day M, Rodeghier M, Gindville MC, Brodsky MA, DeBaun MR, Jordan LC. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia [letter]. Blood [print-electronic]. 2016 Apr 4/21/2016; 127(16): 2038-40. PMID: 26941400, PII: blood-2016-01-694562, DOI: 10.1182/blood-2016-01-694562, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26941400.
  • Alfraih F, Aljurf M, Fitzhugh CD, Kassim AA. Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies. Semin. Hematol [print-electronic]. 2016 Apr; 53(2): 120-8. PMID: 27000737, PII: S0037-1963(16)00002-0, DOI: 10.1053/j.seminhematol.2016.01.001, ISSN: 1532-8686.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27000737.
  • Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R. NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016. J Natl Compr Canc Netw. 2016 Apr; 14(4): 389-400. PMID: 27059188, PII: 14/4/389, ISSN: 1540-1413.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/27059188.
  • Boafor TK, Olayemi E, Galadanci N, Hayfron-Benjamin C, Dei-Adomakoh Y, Segbefia C, Kassim AA, Aliyu MH, Galadanci H, Tuuli MG, Rodeghier M, DeBaun MR, Oppong SA. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG [print-electronic]. 2016 Apr; 123(5): 691-8. PMID: 26667608, DOI: 10.1111/1471-0528.13786, ISSN: 1471-0528.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26667608.
  • Cornell RF, Kassim AA. Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity. Bone Marrow Transplant [print-electronic]. 2016 Apr; 51(4): 479-91. PMID: 26726946, PMCID: PMC4827007, PII: bmt2015307, DOI: 10.1038/bmt.2015.307, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26726946.
  • Halasa NB, Savani BN, Asokan I, Kassim A, Simons R, Summers C, Bourgeois J, Clifton C, Vaughan LA, Lucid C, Wang L, Fonnesbeck C, Jagasia M. Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients. Biol. Blood Marrow Transplant [print-electronic]. 2016 Mar; 22(3): 528-35. PMID: 26705931, PII: S1083-8791(15)01864-9, DOI: 10.1016/j.bbmt.2015.12.003, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26705931.
  • Jordan LC, Gindville MC, Scott AO, Juttukonda MR, Strother MK, Kassim AA, Chen SC, Lu H, Pruthi S, Shyr Y, Donahue MJ. Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia. Brain [print-electronic]. 2016 Mar; 139(Pt 3): 738-50. PMID: 26823369, PII: awv397, DOI: 10.1093/brain/awv397, ISSN: 1460-2156.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26823369.
  • Kassim AA, Payne AB, Rodeghier M, Macklin EA, Strunk RC, DeBaun MR. Low forced expiratory volume is associated with earlier death in sickle cell anemia. Blood [print-electronic]. 2015 Sep 9/24/2015; 126(13): 1544-50. PMID: 26261241, PMCID: PMC4582330, PII: blood-2015-05-644435, DOI: 10.1182/blood-2015-05-644435, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/26261241.
  • Kassim AA, Galadanci NA, Pruthi S, DeBaun MR. How I treat and manage strokes in sickle cell disease. Blood [print-electronic]. 2015 May 5/28/2015; 125(22): 3401-10. PMID: 25824688, PMCID: PMC4467906, PII: blood-2014-09-551564, DOI: 10.1182/blood-2014-09-551564, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25824688.
  • Wolf RB, Saville BR, Roberts DO, Fissell RB, Kassim AA, Airewele G, DeBaun MR. Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort. Am. J. Hematol [print-electronic]. 2015 Jan; 90(1): 2-7. PMID: 25236783, DOI: 10.1002/ajh.23854, ISSN: 1096-8652.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25236783.
  • Das-Gupta E, Greinix H, Jacobs R, Zhou L, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Jagasia M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica [print-electronic]. 2014 Nov; 99(11): 1746-52. PMID: 25150260, PMCID: PMC4222474, PII: haematol.2014.108217, DOI: 10.3324/haematol.2014.108217, ISSN: 1592-8721.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150260.
  • Das-Gupta E, Greinix H, Jacobs R, Zhou L, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Jagasia M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica [print-electronic]. 2014 Nov; 99(11): 1746-52. PMID: 25150260, PMCID: PMC4222474, PII: haematol.2014.108217, DOI: 10.3324/haematol.2014.108217, ISSN: 1592-8721.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150260.
  • Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood [print-electronic]. 2014 Oct 10/16/2014; 124(16): 2596-606. PMID: 25161269, PMCID: PMC4199961, PII: blood-2014-05-576041, DOI: 10.1182/blood-2014-05-576041, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25161269.
  • Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood [print-electronic]. 2014 Oct 10/16/2014; 124(16): 2596-606. PMID: 25161269, PMCID: PMC4199961, PII: blood-2014-05-576041, DOI: 10.1182/blood-2014-05-576041, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25161269.
  • Pauff JM, Gonzalez RS, Sajnani KP, Kassim A, Jagasia M. Post-allograft pomalidomide and reversible hepatotoxicity [letter]. Bone Marrow Transplant [print-electronic]. 2014 Oct; 49(10): 1341-2. PMID: 24955783, PII: bmt2014128, DOI: 10.1038/bmt.2014.128, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24955783.
  • Pauff JM, Gonzalez RS, Sajnani KP, Kassim A, Jagasia M. Post-allograft pomalidomide and reversible hepatotoxicity [letter]. Bone Marrow Transplant [print-electronic]. 2014 Oct; 49(10): 1341-2. PMID: 24955783, PII: bmt2014128, DOI: 10.1038/bmt.2014.128, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24955783.
  • Wolf RB, Kassim AA, Goodpaster RL, DeBaun MR. Nocturnal enuresis in sickle cell disease. Expert Rev Hematol. 2014 Apr; 7(2): 245-54. PMID: 24617333, DOI: 10.1586/17474086.2014.892412, ISSN: 1747-4094.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617333.
  • Wolf RB, Kassim AA, Goodpaster RL, DeBaun MR. Nocturnal enuresis in sickle cell disease. Expert Rev Hematol. 2014 Apr; 7(2): 245-54. PMID: 24617333, DOI: 10.1586/17474086.2014.892412, ISSN: 1747-4094.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617333.
  • Maheshwari S, Kassim A, Yeh RF, Domm J, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Frangoul H, Yang E. Targeted Busulfan therapy with a steady-state concentration of 600-700¿ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Bone Marrow Transplant [print-electronic]. 2014 Mar; 49(3): 366-9. PMID: 24317124, PII: bmt2013188, DOI: 10.1038/bmt.2013.188, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24317124.
  • Maheshwari S, Kassim A, Yeh RF, Domm J, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Frangoul H, Yang E. Targeted Busulfan therapy with a steady-state concentration of 600-700¿ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Bone Marrow Transplant [print-electronic]. 2014 Mar; 49(3): 366-9. PMID: 24317124, PII: bmt2013188, DOI: 10.1038/bmt.2013.188, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24317124.
  • Kassim AA, DeBaun MR. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease. Expert Opin Pharmacother [print-electronic]. 2014 Feb; 15(3): 325-36. PMID: 24392871, DOI: 10.1517/14656566.2014.868435, ISSN: 1744-7666.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24392871.
  • Kassim AA, DeBaun MR. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease. Expert Opin Pharmacother [print-electronic]. 2014 Feb; 15(3): 325-36. PMID: 24392871, DOI: 10.1517/14656566.2014.868435, ISSN: 1744-7666.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24392871.
  • Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant [print-electronic]. 2014 Feb; 49(2): 236-40. PMID: 24096824, PMCID: PMC3946331, PII: bmt2013157, DOI: 10.1038/bmt.2013.157, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24096824.
  • Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant [print-electronic]. 2014 Feb; 49(2): 236-40. PMID: 24096824, PMCID: PMC3946331, PII: bmt2013157, DOI: 10.1038/bmt.2013.157, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24096824.
  • Ragon BK, Clifton C, Chen H, Savani BN, Engelhardt BG, Kassim AA, Vaughan LA, Lucid C, Jagasia M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 53-7. PMID: 24120525, PII: S1083-8791(13)00450-3, DOI: 10.1016/j.bbmt.2013.10.004, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24120525.
  • Ragon BK, Clifton C, Chen H, Savani BN, Engelhardt BG, Kassim AA, Vaughan LA, Lucid C, Jagasia M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 53-7. PMID: 24120525, PII: S1083-8791(13)00450-3, DOI: 10.1016/j.bbmt.2013.10.004, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24120525.
  • Vaughan LA, Vu M, Sengsayadeth S, Lucid C, Clifton C, McCarty K, Hagaman D, Domm J, Kassim A, Chinratanalab W, Goodman S, Greer J, Frangoul H, Engelhardt BG, Jagasia M, Savani BN. New allergies after cord blood transplantation. Cytotherapy. 2013 Oct; 15(10): 1259-65. PMID: 23993300, PII: S1465-3249(13)00550-1, DOI: 10.1016/j.jcyt.2013.05.018, ISSN: 1477-2566.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23993300.
  • Vaughan LA, Vu M, Sengsayadeth S, Lucid C, Clifton C, McCarty K, Hagaman D, Domm J, Kassim A, Chinratanalab W, Goodman S, Greer J, Frangoul H, Engelhardt BG, Jagasia M, Savani BN. New allergies after cord blood transplantation. Cytotherapy. 2013 Oct; 15(10): 1259-65. PMID: 23993300, PII: S1465-3249(13)00550-1, DOI: 10.1016/j.jcyt.2013.05.018, ISSN: 1477-2566.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23993300.
  • Jagasia M, Greinix H, Robin M, Das-Gupta E, Jacobs R, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Socie G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol. Blood Marrow Transplant [print-electronic]. 2013 Jul; 19(7): 1129-33. PMID: 23623892, PII: S1083-8791(13)00186-9, DOI: 10.1016/j.bbmt.2013.04.018, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23623892.
  • Jagasia M, Greinix H, Robin M, Das-Gupta E, Jacobs R, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Socie G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol. Blood Marrow Transplant [print-electronic]. 2013 Jul; 19(7): 1129-33. PMID: 23623892, PII: S1083-8791(13)00186-9, DOI: 10.1016/j.bbmt.2013.04.018, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23623892.
  • Kassim AA, DeBaun MR. Sickle cell disease, vasculopathy, and therapeutics. Annu. Rev. Med [print-electronic]. 2013; 64: 451-66. PMID: 23190149, DOI: 10.1146/annurev-med-120611-143127, ISSN: 1545-326X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23190149.
  • Kassim AA, DeBaun MR. Sickle cell disease, vasculopathy, and therapeutics. Annu. Rev. Med [print-electronic]. 2013; 64: 451-66. PMID: 23190149, DOI: 10.1146/annurev-med-120611-143127, ISSN: 1545-326X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23190149.
  • Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp. Hematol [print-electronic]. 2012 Dec; 40(12): 974-982.e1. PMID: 22885125, PMCID: PMC3611587, PII: S0301-472X(12)00343-8, DOI: 10.1016/j.exphem.2012.08.002, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22885125.
  • Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp. Hematol [print-electronic]. 2012 Dec; 40(12): 974-982.e1. PMID: 22885125, PMCID: PMC3611587, PII: S0301-472X(12)00343-8, DOI: 10.1016/j.exphem.2012.08.002, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22885125.
  • Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A. Minimal residual disease in myeloma: are we there yet?. Biol. Blood Marrow Transplant [print-electronic]. 2012 Dec; 18(12): 1790-9. PMID: 22626785, PII: S1083-8791(12)00211-X, DOI: 10.1016/j.bbmt.2012.05.009, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22626785.
  • Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A. Minimal residual disease in myeloma: are we there yet?. Biol. Blood Marrow Transplant [print-electronic]. 2012 Dec; 18(12): 1790-9. PMID: 22626785, PII: S1083-8791(12)00211-X, DOI: 10.1016/j.bbmt.2012.05.009, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22626785.
  • Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant [print-electronic]. 2012 Dec; 47(12): 1535-7. PMID: 22659680, PII: bmt201288, DOI: 10.1038/bmt.2012.88, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22659680.
  • Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant [print-electronic]. 2012 Dec; 47(12): 1535-7. PMID: 22659680, PII: bmt201288, DOI: 10.1038/bmt.2012.88, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22659680.
  • Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Lucid C, Vaughan LA, Savani BN, Jagasia M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant [print-electronic]. 2012 Nov; 47(11): 1470-3. PMID: 22484321, PII: bmt201256, DOI: 10.1038/bmt.2012.56, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22484321.
  • Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Lucid C, Vaughan LA, Savani BN, Jagasia M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant [print-electronic]. 2012 Nov; 47(11): 1470-3. PMID: 22484321, PII: bmt201256, DOI: 10.1038/bmt.2012.56, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22484321.
  • Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2012 Jul; 18(7): 1069-75. PMID: 22178694, PII: S1083-8791(11)01080-9, DOI: 10.1016/j.bbmt.2011.12.518, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22178694.
  • Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269114.
  • Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269114.
  • Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269117.
  • Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PMCID: PMC4845757, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269117.
  • Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood [print-electronic]. 2012 Mar 3/8/2012; 119(10): 2417-21. PMID: 22262764, PMCID: PMC3311262, PII: blood-2011-10-384750, DOI: 10.1182/blood-2011-10-384750, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22262764.
  • Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood [print-electronic]. 2012 Mar 3/8/2012; 119(10): 2417-21. PMID: 22262764, PMCID: PMC3311262, PII: blood-2011-10-384750, DOI: 10.1182/blood-2011-10-384750, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22262764.
  • Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, Savani BN, Kassim A, Greer JP, Schuening FG, Engelhardt BG, Jagasia MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood [print-electronic]. 2011 Jul 7/28/2011; 118(4): 1140-4. PMID: 21628416, PII: blood-2010-09-310011, DOI: 10.1182/blood-2010-09-310011, ISSN: 1528-0020.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21628416.
  • Figaro MK, Clayton W, Usoh C, Brown K, Kassim A, Lakhani VT, Jagasia S. Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: results of a retrospective case review. Am. J. Hematol [print-electronic]. 2011 Jun; 86(6): 467-70. PMID: 21544854, DOI: 10.1002/ajh.22008, ISSN: 1096-8652.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21544854.
  • Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE. Regulatory T cell expression of CLA or a(4)ß(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 436-42. PMID: 20577222, PMCID: PMC3217583, PII: bmt2010127, DOI: 10.1038/bmt.2010.127, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20577222.
  • Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 426-9. PMID: 20581885, PII: bmt2010152, DOI: 10.1038/bmt.2010.152, ISSN: 1476-5365.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20581885.
  • Griffith ML, Jagasia MH, Misfeldt AA, Chen H, Engelhardt BG, Kassim A, Savani BN, Survant M, Jagasia SM. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2011 Jan; 17(1): 86-92. PMID: 20561594, PII: S1083-8791(10)00254-5, DOI: 10.1016/j.bbmt.2010.06.010, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20561594.
  • Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, Greenhut SL, Goodman S, Greer JP, Schuening F, Frangoul H, Savani BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy [print-electronic]. 2011 Jan; 13(1): 78-82. PMID: 20586668, DOI: 10.3109/14653249.2010.495114, ISSN: 1477-2566.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20586668.
  • Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol. Blood Marrow Transplant [print-electronic]. 2009 Oct; 15(10): 1288-95. PMID: 19747637, PMCID: PMC3159406, PII: S1083-8791(09)00289-4, DOI: 10.1016/j.bbmt.2009.06.007, ISSN: 1523-6536.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19747637.
  • Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, Morgan D, Ruffner K, Schuening F. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol. Blood Marrow Transplant [print-electronic]. 2007 Oct; 13(10): 1207-15. PMID: 17889358, PII: S1083-8791(07)00338-2, DOI: 10.1016/j.bbmt.2007.07.001, ISSN: 1083-8791.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17889358.
  • Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk. Lymphoma. 2007 Sep; 48(9): 1728-35. PMID: 17786708, PII: 781802102, DOI: 10.1080/10428190701534374, ISSN: 1042-8194.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17786708.
  • Miller GG, Boivin G, Dummer JS, McConnell T, Becher MW, Kassim A, Tang YW. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. Clin. Infect. Dis [print-electronic]. 2006 Feb 2/15/2006; 42(4): e26-9. PMID: 16421783, PII: CID37885, DOI: 10.1086/499366, ISSN: 1537-6591.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16421783.
  • Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'. Bone Marrow Transplant. 2005 Oct; 36(7): 565-74. PMID: 15995714, PII: 1705075, DOI: 10.1038/sj.bmt.1705075, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15995714.
  • Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Bone Marrow Transplant. 2005 Jun; 35(12): 1165-9. PMID: 15880129, PII: 1704994, DOI: 10.1038/sj.bmt.1704994, ISSN: 0268-3369.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15880129.
  • Kassim AA, Fabry ME, Nagel RL. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait. (Letter). Blood. 2000; 1;95((5)): 1878-9.
  • Kassim AA, Umans H, Nagel RL, Fabry ME. Megalophallus as a sequela of priapism in sickle cell anemia: use of blood oxygen level-dependent magnetic resonance imaging. Urology. 2000; 1;56((3)): 509.
  • Fabry, M.E., Liu, G., Kassim, A., Billet, H., Nagel, R.L. Deoxy HbS detection in brain of sickle cell disease patients by blood level oxygen dependent magnetic resonance imaging (BOLD-MRI). (Abstract). Blood. 1999; ((94)): 421a.
  • Fabry, M.E., Kassim, A., Umans, H., Nagel, R.L. Clinical applications of BOLD-MRI to extremities in sickle cell pain episodes. (Abstract). Blood. 1998; ((9, 92)): 525a.
  • Kassim, A., Sane, P., Billett, H. Tower skill or marrow expansion with pituitary hemosiderosis in beta thalassemia intermedia. Journal of Radiology.